Home > Drug Search >
  • company_query: Axovant
  •   > 
Drug Filter
Category:
chemistry (17) biology (3)
Status:
Phase Ⅲ (2) Phase Ⅱ (11) Phase Ⅰ (7)
Clinical Stage:
Pending (2) Active (11) Discontinued (7)
Bio-Type:
Recombinant enzyme (1) Other recombinant protein (1) Whole antibody (1)
Indication:
Acute coronary syndrome (ACS) (1) Alzheimer's disease (AD) (1) Brain ischemia (1) Crohn's disease (1) Delayed graft function (1) Cutaneous T cell lymphoma (CTCL) (1) Cystic fibrosis (CF) (1) Transplant rejection (1) Gastric cancer (1) Gaucher's disease (GD) (1) Metastatic breast cancer (1) Non small cell lung cancer (NSCLC) (1) Obesity (1) Pancreatic cancer (1) Lipid metabolism disorders (1) Primary hypogonadism (1) Psoriasis (1) Small cell lung cancer (SCLC) (1) Solid tumours (4) Neuroblastoma (1) Sickle cell disease (1) Thymic tumor (1) Thrombosis (1) Cerebral edema diabetic ketoacidosis (1) Hipovolemic shock (1) Thelassemia (1) Hypoxemia (1) Urination disorders (1) Scleroderma (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top